Ketamine Use in Palliative Care #132

[1] Ketamine as aduvant to opioids for cancer pain. A qualitative systematic review [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 26 (03) : 867 - 875

[2] Dickman A., 2005, The syringe driver: continuous subcutaneous infusions in palliative care, V2A

[3] Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes [J]. DRUG METABOLISM AND DISPOSITION, 2002, 30 (07) : 853 - 858

[4] Subanesthetic ketamine: An essential adjuvant for intractable cancer pain [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 28 (02) : 100 - 102

[5] Kronenberg Robert H, 2002, J Pain Palliat Care Pharmacother, V16, P27

[6] MECHANISMS OF HYPERALGESIA AND MORPHINE-TOLERANCE - A CURRENT VIEW OF THEIR POSSIBLE INTERACTIONS [J]. PAIN, 1995, 62 (03) : 259 - 274

[7] Okon Tomasz, 2007, Pain Physician, V10, P493

[8] Taylor BJ, 2009, J AM ASSOC LAB ANIM, V48, P718

[9] Ketamine - From medicine to misuse [J]. CNS DRUGS, 2006, 20 (03) : 199 - 218

[1] Ketamine as aduvant to opioids for cancer pain. A qualitative systematic review [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 26 (03) : 867 - 875

[2] Dickman A., 2005, The syringe driver: continuous subcutaneous infusions in palliative care, V2A

[3] Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes [J]. DRUG METABOLISM AND DISPOSITION, 2002, 30 (07) : 853 - 858

[4] Subanesthetic ketamine: An essential adjuvant for intractable cancer pain [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 28 (02) : 100 - 102

[5] Kronenberg Robert H, 2002, J Pain Palliat Care Pharmacother, V16, P27

[6] MECHANISMS OF HYPERALGESIA AND MORPHINE-TOLERANCE - A CURRENT VIEW OF THEIR POSSIBLE INTERACTIONS [J]. PAIN, 1995, 62 (03) : 259 - 274

[7] Okon Tomasz, 2007, Pain Physician, V10, P493

[8] Taylor BJ, 2009, J AM ASSOC LAB ANIM, V48, P718

[9] Ketamine - From medicine to misuse [J]. CNS DRUGS, 2006, 20 (03) : 199 - 218